|
[Related PubMed/MEDLINE]
Total Number of Papers: 3714
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: S1P |
| Long Form |
: sphingosine-1-phosphate |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
A 50-Hz magnetic-field exposure promotes human amniotic cells proliferation via SphK-S1P-S1PR cascade mediated ERK signaling pathway. |
ELF-EMFs, ERK, MF, S1PR, SphK1 |
| 2 |
2020 |
A novel sphingosylphosphorylcholine and sphingosine-1-phosphate receptor 1 antagonist, KRO-105714, for alleviating atopic dermatitis. |
HTS, S1P1, SM, SPC |
| 3 |
2020 |
A Novel Type of Stem Cells Double-Positive for SSEA-3 and CD45 in Human Peripheral Blood. |
Muse, PB |
| 4 |
2020 |
A Sphingosine 1-Phosphate Gradient Is Linked to the Cerebral Recruitment of T Helper and Regulatory T Helper Cells during Acute Ischemic Stroke. |
MCAO, S1PR, Th, Treg |
| 5 |
2020 |
A Sphingosine-1-Phosphate Modulator Ameliorates Polycystic Kidney Disease in Han:SPRD Rats. |
PKD, STAT3 |
| 6 |
2020 |
Activation of sphingosine 1-phosphate receptor 2 attenuates chemotherapy-induced neuropathy. |
--- |
| 7 |
2020 |
Activation of sphingosine-1-phosphate receptor subtype 1 in the central nervous system contributes to morphine-induced hyperalgesia and antinociceptive tolerance in rodents. |
OIH, S1PR1, S1PR1-5 |
| 8 |
2020 |
Adenosine A2B receptors inhibit K+ currents and cell differentiation in cultured oligodendrocyte precursor cells and modulate sphingosine-1-phosphate signaling pathway. |
A2BR, SphK1 |
| 9 |
2020 |
Advancements in understanding the role of lysophospholipids and their receptors in lung disorders including bronchopulmonary dysplasia. |
BPD, LPA, LPL |
| 10 |
2020 |
Advances in Neurobiology and Pharmacology of GPR12. |
CBD, CNS, IUPHAR, SPC |
| 11 |
2020 |
Aging Suppresses Sphingosine-1-Phosphate Chaperone ApoM in Circulation Resulting in Maladaptive Organ Repair. |
apoM, HDL, S1PR1 |
| 12 |
2020 |
Amitriptyline inhibits nonalcoholic steatohepatitis and atherosclerosis induced by high-fat diet and LPS through modulation of sphingolipid metabolism. |
ASMase, HP-HFD, LPS, NASH, PA |
| 13 |
2020 |
An adiponectin-S1P autocrine axis protects skeletal muscle cells from palmitate-induced cell death. |
ROS |
| 14 |
2020 |
Angiocrine Sphingosine-1-Phosphate Activation of S1PR2-YAP Signaling Axis in Alveolar Type II Cells Is Essential for Lung Repair. |
LMVECs, SphK1, YAP |
| 15 |
2020 |
Antiproliferative Effects of Thymoquinone in MCF-7 Breast and HepG2 Liver Cancer Cells: Possible Role of Ceramide and ER Stress. |
C1P, Cer, GRP78, NFkappaB1, nSMase, SM, TQ |
| 16 |
2020 |
Apolipoprotein M: new connections with diet, adipose tissue and metabolic syndrome. |
apoM |
| 17 |
2020 |
Apolipoprotein M: Research Progress and Clinical Perspective. |
apoM, HDL, MHC |
| 18 |
2020 |
Association of circulating levels of total and protein-bound sphingosine 1-phosphate with osteoporotic fracture. |
BMD, HDL, LDL, OF |
| 19 |
2020 |
Associations with metabolites in Chinese suggest new metabolic roles in Alzheimer's and Parkinson's diseases. |
--- |
| 20 |
2020 |
beta3-adrenoreceptor blockade reduces tumor growth and increases neuronal differentiation in neuroblastoma via SK2/S1P2 modulation. |
beta3-AR, NB, S1P2, SK2 |
| 21 |
2020 |
Blockage of sphingosine-1-phosphate receptor 2 attenuates 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice. |
BMDCs, DNCB, S1P2 |
| 22 |
2020 |
Blocking sphingosine 1-phosphate receptor 2 accelerates hepatocellular carcinoma progression in a mouse model of NASH. |
DG, GNMT, HCC, MC4R, NASH, S1PRs, TG, WD |
| 23 |
2020 |
Bone regenerative potential of the selective sphingosine 1-phosphate receptor modulator siponimod: In vitro characterisation using osteoblast and endothelial cells. |
--- |
| 24 |
2020 |
Cardiovascular Effects of Pharmacological Targeting of Sphingosine Kinase 1. |
PKC |
| 25 |
2020 |
Cell Death in the Tumor Microenvironment: Implications for Cancer Immunotherapy. |
LPC |
| 26 |
2020 |
Ceramide and Sphingosine 1-Phosphate in Liver Diseases. |
--- |
| 27 |
2020 |
Chemical genetic analysis of FTY720- and Ca2+ -sensitive mutants reveals a functional connection between FTY720 and membrane trafficking. |
fcs mutants |
| 28 |
2020 |
Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity. |
CBD, Cer, HFD, HPLC, IR |
| 29 |
2020 |
Circulating cord blood HDL-S1P complex preserves the integrity of the feto-placental vasculature. |
PLC |
| 30 |
2020 |
Combined Omics Approach Identifies Gambogic Acid and Related Xanthones as Covalent Inhibitors of the Serine Palmitoyltransferase Complex. |
--- |
| 31 |
2020 |
Current, New and Future Therapeutic Targets in Inflammatory Bowel Disease: A Systematic Review. |
CD, IBD, IL, JAK, TNF, UC |
| 32 |
2020 |
Dabigatran Suppresses PAR-1/SphK/S1P Activation of Astrocytes in Experimental Autoimmune Encephalomyelitis Model. |
CNS, EAE, MS, PAR-1, SphKs |
| 33 |
2020 |
Declining BRCA-Mediated DNA Repair in Sperm Aging and its Prevention by Sphingosine-1-Phosphate. |
DSB, WT |
| 34 |
2020 |
Decoding the Role of Sphingosine-1-Phosphate in Asthma and Other Respiratory System Diseases Using Next Generation Knowledge Discovery Platforms Coupled With Luminex Multiple Analyte Profiling Technology. |
S1PRs, SphK1 |
| 35 |
2020 |
Defects in High Density Lipoprotein metabolism and hepatic steatosis in mice with liver-specific ablation of Hepatocyte Nuclear Factor 4A. |
ChIP, HDL, NAFLD |
| 36 |
2020 |
Dental regenerative therapy targeting sphingosine-1-phosphate (S1P) signaling pathway in endodontics. |
DPSCs |
| 37 |
2020 |
Detrimental role of sphingosine kinase 1 in kidney damage in DOCA-salt hypertensive model: evidence from knockout mice. |
DOCA, KO, WT, WT-C |
| 38 |
2020 |
Development and validation of a QTrap method for sensitive quantification of sphingosine 1-phosphate. |
EPI, MRM |
| 39 |
2020 |
Development of electrospun polymer scaffolds for the localized and controlled delivery of siponimod for the management of critical bone defects. |
PLGA |
| 40 |
2020 |
Discovery of a Small Side Cavity in Sphingosine Kinase 2 that Enhances Inhibitor Potency and Selectivity. |
Sph |
| 41 |
2020 |
Discovery of fingolimod based on the chemical modification of a natural product from the fungus, Isaria sinclairii. |
MS, S1P1 |
| 42 |
2020 |
Downregulation of S1P Lyase Improves Barrier Function in Human Cerebral Microvascular Endothelial Cells Following an Inflammatory Challenge. |
iS1P |
| 43 |
2020 |
Druggable Lipid GPCRs: Past, Present, and Prospects. |
FFAs, GPCRs, mAbs, PAF, SPMs |
| 44 |
2020 |
Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities. |
--- |
| 45 |
2020 |
Effect of sphingosine-1-phosphate on activation of dormant follicles in murine and human ovarian tissue. |
--- |
| 46 |
2020 |
Effects of fingolimod, a sphingosine-1-phosphate (S1P) receptor agonist, on white matter microstructure, cognition and symptoms in schizophrenia. |
DTI, FA, MS, WM |
| 47 |
2020 |
Effects of sphingolipids overload on red blood cell properties in Gaucher disease. |
GD, RBCs, SL, Sph |
| 48 |
2020 |
Effects of triptolide on the sphingosine kinase - Sphingosine-1-phosphate signaling pathway in colitis-associated colon cancer. |
AOM, CACC, DSS, SphK, TP |
| 49 |
2020 |
Endothelial S1pr1 regulates pressure overload-induced cardiac remodelling through AKT-eNOS pathway. |
Ang II, CM, ECs, NO, TAC |
| 50 |
2020 |
Enhanced inflammasome activation and reduced sphingosine-1 phosphate S1P signalling in a respiratory mucoobstructive disease model. |
betaENaC, SphK1, Spns2 |
| 51 |
2020 |
Entosis and apical cell extrusion constitute a tumor-suppressive mechanism downstream of Matriptase. |
PLD |
| 52 |
2020 |
Erythrocyte adaptive metabolic reprogramming under physiological and pathological hypoxia. |
2,3-BPG, CKD, deoxyHbS, eENT1, SCD |
| 53 |
2020 |
Erythrocyte Metabolic Reprogramming by Sphingosine 1-Phosphate in Chronic Kidney Disease and Therapies. |
AMPK, CKD, PP2A |
| 54 |
2020 |
Establishment of a Measurement System for Sphingolipids in the Cerebrospinal Fluid Based on Liquid Chromatography-Tandem Mass Spectrometry, and Its Application in the Diagnosis of Carcinomatous Meningitis. |
CSF, dhS1P |
| 55 |
2020 |
Evaluating the antitumor activity of sphingosine-1-phosphate against human triple-negative breast cancer cells with basal-like morphology. |
TNBC-BL |
| 56 |
2020 |
Evaluation of oxysterol levels of patients with silicosis by LC-MS/MS method. |
4-HNE, MDA |
| 57 |
2020 |
Evidence for Altered Metabolism of Sphingosine-1-Phosphate in the Corpus Callosum of Patients with Schizophrenia. |
--- |
| 58 |
2020 |
Evidence that ABC transporter-mediated autocrine export of an eicosanoid signaling molecule enhances germ cell chemotaxis in the colonial tunicate Botryllus schlosseri. |
GSCs, LOX, PLA2 |
| 59 |
2020 |
Exogenous dihydrosphingosine 1 phosphate mediates collagen synthesis in cardiac fibroblasts through JAK/STAT signalling and regulation of TIMP1. |
dhS1P, HDL, HF, JAK/STAT, NCFs, NCMs, S1PR1, TGF-beta, TIMP1 |
| 60 |
2020 |
Expression and role of Sphingosine 1-phosphate receptors in intervertebral disc degeneration. |
ADAMTS4, IVD, MMP-3, NP |
| 61 |
2020 |
Finding a Way Out: S1P Signaling and Immune Cell Migration. |
--- |
| 62 |
2020 |
Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis. |
MS |
| 63 |
2020 |
Fingolimod inhibits multiple stages of the HIV-1 life cycle. |
ART, HIV |
| 64 |
2020 |
Floralozone Ameliorated Atherosclerosis in Experimental Atherosclerotic Rats Involved with Sphingosine 1-Phosphate 1 Enhancement. |
AS, IL |
| 65 |
2020 |
From molecular mechanism to pre-clinical results: Anti-epileptic effects of Fingolimod. |
AEDs, RRMS |
| 66 |
2020 |
FTY720 (Fingolimod) Ameliorates Brain Injury through Multiple Mechanisms and is a Strong Candidate for Stroke Treatment. |
BBB, FDA |
| 67 |
2020 |
FTY720 ameliorates GvHD by blocking T lymphocyte migration to target organs and by skin fibrosis inhibition. |
GVHD |
| 68 |
2020 |
FTY720 reactivates cryptococcal granulomas in mice through S1P receptor 3 on macrophages. |
MS |
| 69 |
2020 |
FTY720 Regulates Mitochondria Biogenesis in Dendritic Cells to Prevent Kidney Ischemic Reperfusion Injury. |
BMDCs, DCs, FTY-DCs, IRI, Veh-DCs, WT |
| 70 |
2020 |
Functional contribution of sphingosine-1-phosphate to airway pathology in cigarette smoke-exposed mice. |
COPD |
| 71 |
2020 |
Generation of sphingosine-1-phosphate by sphingosine kinase 1 protects nonalcoholic fatty liver from ischemia/reperfusion injury through alleviating reactive oxygen species production in hepatocytes. |
I/R, NAFL, ROS, SphK1 |
| 72 |
2020 |
Glycans Meet Sphingolipids: Structure-Based Design of Glycan Containing Analogues of a Sphingosine Kinase Inhibitor. |
--- |
| 73 |
2020 |
Glycation of HDL Polymerizes Apolipoprotein M and Attenuates Its Capacity to Bind to Sphingosine 1-Phosphate. |
apoM, HDL |
| 74 |
2020 |
HDL-S1P protects endothelial function and reduces lung injury during sepsis in vivo and in vitro. |
CLP, HDL, LPS |
| 75 |
2020 |
Hepatic insulin resistance induced by mitochondrial oxidative stress can be ameliorated by sphingosine 1-phosphate. |
IR, ROS |
| 76 |
2020 |
High Circulating Sphingosine 1-Phosphate is a Risk Factor for Osteoporotic Fracture Independent of Fracture Risk Assessment Tool. |
AUC, CI, OF, OR |
| 77 |
2020 |
Identification of a 22bp DNA cis Element that Plays a Critical Role in Colony Stimulating Factor 1-Dependent Transcriptional Activation of the SPHK1 Gene. |
CSF1, SphK1 |
| 78 |
2020 |
Identification of Brain-Specific Treatment Effects in NPC1 Disease by Focusing on Cellular and Molecular Changes of Sphingosine-1-Phosphate Metabolism. |
HP-beta-CD, HPTLC, iPSCs, NPC1, qRT-PCR, S1PR |
| 79 |
2020 |
Impact of S1P Mimetics on Mesenteric Ischemia/Reperfusion Injury. |
I/R |
| 80 |
2020 |
In silico Docking Studies of Fingolimod and S1P1 Agonists. |
EDG-1, GPCRs, MOE, S1P1, S1PR |
| 81 |
2020 |
Increased S1P induces S1PR2 internalization to blunt the sensitivity of colorectal cancer to 5-fluorouracil via promoting intracellular uracil generation. |
5-FU, CRC, ER, PM, S1PRs |
| 82 |
2020 |
Inflammatory Conditions Disrupt Constitutive Endothelial Cell Barrier Stabilization by Alleviating Autonomous Secretion of Sphingosine 1-Phosphate. |
BALF, EC, ECIS, FITC, HUVEC, LPS, S1PR1 |
| 83 |
2020 |
Inhibition of S1P Receptor 2 Attenuates Endothelial Dysfunction and Inhibits Atherogenesis in Apolipoprotein E-Deficient Mice. |
HUVEC, S1P2, WTD |
| 84 |
2020 |
Inhibition of sphingosine 1-phosphate lyase activates human keratinocyte differentiation and attenuates psoriasis in mice. |
HEKn, IL, siSGPL1 |
| 85 |
2020 |
Inhibition of store-operated calcium channels by N-arachidonoyl glycine (NAGly): no evidence for the involvement of lipid-sensing G protein coupled receptors. |
AEA, CNS, GPCRs, LPA, NAGly |
| 86 |
2020 |
Inhibitors of Ceramide- and Sphingosine-Metabolizing Enzymes as Sensitizers in Radiotherapy and Chemotherapy for Head and Neck Squamous Cell Carcinoma. |
C1P, HNSCC |
| 87 |
2020 |
Interaction between nitric oxide and storage temperature on sphingolipid metabolism of postharvest peach fruit. |
ALP, AP, C1P, Cer, CERK, CerS, KDSR, NO, PLA, PLC, PLD, SM, SMS, Sph, SphK |
| 88 |
2020 |
Interleukin-22 Mediates the Chemotactic Migration of Breast Cancer Cells and Macrophage Infiltration of the Bone Microenvironment by Potentiating S1P/SIPR Signaling. |
IL-22, IL-22R1, MMP-9, MSCs, S1PR1 |
| 89 |
2020 |
Intra-Tumoral Angiogenesis Is Associated with Inflammation, Immune Reaction and Metastatic Recurrence in Breast Cancer. |
IL, METABRIC, TNF |
| 90 |
2020 |
Ion Binding Properties of a Naturally Occurring Metalloantibody. |
FAAS, ICP-MS, ITC |
| 91 |
2020 |
Is there a role for therapeutic sphingolipids in inflammatory bowel disease? |
IBD |
| 92 |
2020 |
JTE-013 supplementation improves erectile dysfunction in rats with streptozotocin-induced type Ⅰ diabetes through the inhibition of the rho-kinase pathway, fibrosis, and apoptosis. |
DM, DMED, ED, p-MYPT1, S1PR2 |
| 93 |
2020 |
L-cysteine/cystathionine-beta-synthase-induced relaxation in mouse aorta involves a L-serine/sphingosine-1-phosphate/NO pathway. |
CBS, SPT |
| 94 |
2020 |
Lipid metabolism adaptations are reduced in human compared to murine Schwann cells following injury. |
SC |
| 95 |
2020 |
Lipid Phosphate Phosphatases and Cancer. |
LPA, LPPs, Plpp |
| 96 |
2020 |
Long-term use of fluoxetine accelerates bone loss through the disruption of sphingolipids metabolism in bone marrow adipose tissue. |
ASM, BMAT, RANKL |
| 97 |
2020 |
Lysophospholipids and Their G-Coupled Protein Signaling in Alzheimer's Disease: From Physiological Performance to Pathological Impairment. |
AD, GPCR, LPA, LPLs, NFTs, PLs, SLs |
| 98 |
2020 |
Macrophage Sphingosine 1-Phosphate Receptor 2 Blockade Attenuates Liver Inflammation and Fibrogenesis Triggered by NLRP3 Inflammasome. |
BM, GeRP, NLRP3, S1PR, SphK1 |
| 99 |
2020 |
Mechanism of action of s1p receptor modulators in multiple sclerosis: The double requirement. |
MS |
| 100 |
2020 |
Mechanism of sphingosine 1-phosphate clearance from blood. |
SphK2 |
|
A Search Service for Abbreviation / Long Form
